Rapid improvement in organ procurement organization performance: Potential for change and impact of new leadership.
donors and donation: deceased
health services and outcomes research
law/legislation
organ procurement and allocation
organ procurement organization
Journal
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
26
03
2020
revised:
29
04
2020
accepted:
15
05
2020
pubmed:
2
6
2020
medline:
22
6
2021
entrez:
2
6
2020
Statut:
ppublish
Résumé
Recently proposed rulemaking from Centers for Medicare and Medicaid Services would change how organ procurement organizations (OPOs) are evaluated. The proposals include using national inpatient death data to define a standardized denominator to calculate comparable donation rates among OPOs. Based on these objective metrics, OPOs not performing at a prespecified threshold will be required to rapidly improve performance to avoid decertification. We sought to determine whether rapid OPO improvement was possible based on objective donation metrics, and whether leadership change was associated with rapid improvement. We evaluated United Network for Organ Sharing and Centers for Disease Control and Prevention (CDC) data from 2011 to 2018, and measured donation rates using CDC data on inpatient deaths from causes consistent with donation, based on the location of deaths. During the two 4-year cycles, we found that an OPO's ranking relative to other OPOs was fairly static, with more than 90% of the OPOs at risk of flagging at the end of each 4-year cycle (2014, 2018) being in the bottom 75% of OPOs in the preceding 3 years. In multivariable logistic regression models, leadership changes were only statistically significantly associated with an improvement in OPO rankings during the 2011-2014 cycle. These data demonstrate that rapid improvements in OPO performance are uncommon, and while leadership changes increase the odds of rapid improvement, they do not guarantee improvement.
Identifiants
pubmed: 32476235
doi: 10.1111/ajt.16085
pii: S1600-6135(22)21637-2
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3567-3573Informations de copyright
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.
Références
Organ Procurement Organization (OPO) Conditions for Coverage Proposed Rule: Revisions to Outcome Measures for OPOs. CMS.gov2019.
Goldberg D, Doby B, Siminoff L, Shah M, Lynch R. Rejecting bias: the case against race adjustment for OPO performance in communities of color. Am J Transplant. 2020. https://doi.org/10.1111/ajt.15865
Goldberg D, Karp S, Shah MB, Dubay D, Lynch R. Importance of incorporating standardized, verifiable, objective metrics of organ procurement organization performance into discussions about organ allocation. Am J Transplant. 2019;19(11):2973-2978.
Goldberg D, Lynch R. Response to: deceased donors: defining drug-related deaths. Clin Transplant. 2020;34(5):e13828.
Goldberg DS, Doby B, Lynch R. Addressing critiques of the proposed cms metric of organ procurement organ performance: more data isn't better. Transplantation. 2019. https://doi.org/10.1097/TP.0000000000003071
Centers for Medicare & Medicaid Services (CMS), HHS. Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Outcome Measure Requirements for Organ Procurement Organization; 42 CFR Part 486, CMS-3380-P. https://www.federalregister.gov/documents/2019/12/23/2019-27418/medicare-and-medicaid-programs-organ-procurement-organizations-conditions-for-coverage-revisions-to. Updated 12/19/2019. Accessed Apr 2, 2020.
Snyder JJ, Musgrove D, Zaun D, et al. The Centers for Medicare and Medicaid Services' proposed metrics for recertification of organ procurement organizations: evaluation by the Scientific Registry of Transplant Recipients. Am J Transplant. 2020. https://doi.org/10.1111/ajt.15842
Kavanagh MH, Ashkanasy NM. The impact of leadership and change management strategy on organizational culture and individual acceptance of change during a merger. Br J Manag. 2006;17(S1):S81-S103.
McAlearney AS. Using leadership development programs to improve quality and efficiency in healthcare. J Healthc Manag. 2008;53(5):319-331.
Day C, Gu Q, Sammons P. The impact of leadership on student outcomes: how successful school leaders use transformational and instructional strategies to make a difference. Educ Admin Quart. 2016;52(2):221-258.
Murphy KJ, Zimmerman JL. Financial performance surrounding CEO turnover. J Acc Econ. 1993;16:273-315.
Dimophoulos T, Wagner HF. Cause and Effect in CEO Changes. London, UK: Department of Finance London Business School. 2010.
Barron JM, Chulkov DV, Waddell GR. Top management team turnover, CEO succession type, and strategic change. J Bus Res. 2011;64(8):904-910.
Beaulieu ND, Dafny LS, Landon BE, Dalton JB, Kuye I, McWilliams JM. Changes in quality of care after hospital mergers and acquisitions. N Engl J Med. 2020;382(1):51-59.
Lee S-YD, Alexander JA. Consequences of organizational change in U.S. hospitals. Med Care Res Rev. 1999;56(3):227-276.
Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Outcome Measure Requirements for Organ Procurement Organization (Complete Document) Federalregister.gov2019.
Sheehy E, O'Connor KJ, Luskin RS, et al. Investigating geographic variation in mortality in the context of organ donation. Am J Transplant. 2012;12(6):1598-1602.
Cannon RM, Jones CM, Davis EG, Franklin GA, Gupta M, Shah MB. Patterns of geographic variability in mortality and eligible deaths between organ procurement organizations. Am J Transplant. 2019;19(10):2756-2763.
OneLegacy GR. Local hospitals, families and donors combine to break all-time donation records for 5th year in a row. Business Wire2020.
Potluri VS, Goldberg DS, Mohan S, et al. National trends in utilization and 1-year outcomes with transplantation of HCV-viremic kidneys. J Am Soc Nephrol. 2019;30(10):1939-1951.
Dezso CL. Entrenchment and changes in performance following CEO turnover. Atlanta Competitive Advantage Conference Paper. 2007;6-103. https://doi.org/10.2139/ssrn.1089121
Godfrey J, Mather P, Ramsay A. Earnings and impression management in financial reports: The case of CEO changes. Abacus. 2003;39:95-123.
Alexander JA, Lee S-YD. The effects of CEO succession and tenure on failure of rural community hospitals. J Appl Behav Sci. 1996;32(1):70-88.
Lee S-YD, Alexander JA. Managing hospitals in turbulent times: do organizational changes improve hospital survival? Health Serv Res. 1999;34(4):923-946.
Ford EW, Lowe KB, Silvera GB, Babik D, Huerta TR. Insider versus outsider executive succession: the relationship to hospital efficiency. Health Care Manage Rev. 2018;43(1):61-68.
Patra K. Browns fire Freddie Kitchens after just one season. https://www.nfl.com/news/browns-fire-freddie-kitchens-after-just-one-season-0ap3000001093133. Accessed January 5, 2020.
Orlowski JP. Envisioning and leading organizational transformation: one organ procurement organization's journey. Cureus. 2016;8(11):e879-e879.
The Bridgespan Group. Reforming organ donation in America. Reforming Organ Donation in America. 2019. https://www.bridgespan.org/bridgespan/Images/articles/reforming-organ-donation-in-america/reforming-organ-donation-in-america-01-2019.pdf. Accessed February 14, 2020.
Wojda TR, Stawicki SP, Yandle KP, et al. Keys to successful organ procurement: an experience-based review of clinical practices at a high-performing health-care organization. Int J Crit Illn Inj Sci. 2017;7(2):91-100.
Mehra MR, Jarcho JA, Cherikh W, et al. The drug-intoxication epidemic and solid-organ transplantation. N Engl J Med. 2018;378(20):1943-1945.